50428 Federal Register / Vol. 82, No. 209 / Tuesday, October 31, 2017 / Notices 

natural and human environment and 

determined that the proposed action 

would not result in significant adverse 

impacts. Based on the results of the 

Final EA, CDC has issued a FONSI 

indicating the proposed action will not 

have a significant impact on the 

environment. The Build Alternative will 

be undertaken in accordance with the 

best management practices (BMPs), 

minimization and mitigation measures 

as presented in the Final EA and FONSI. 

Dated: October 25, 2017. 

Sandra Cashman, 

Executive Secretary, Centers for Disease 

Control and Prevention. 

[FR Doc. 2017–23668 Filed 10–30–17; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

[Docket No. CDC–2017–0103] 

Request for Information on Effective, 

Large-Scale, Sustainable Approaches 

To Help People Quit Using Tobacco by 

Employing Evidence-Based Treatment 

Options 

AGENCY: Centers for Disease Control and 

Prevention, Department of Health and 

Human Services (HHS). 

ACTION: Request for information. 

SUMMARY: The Centers for Disease 

Control and Prevention (CDC) within 

the Department of Health and Human 

Services (HHS) is requesting 

information from the public to inform 

future activities regarding how to 

efficiently and cost effectively help 

people quit using tobacco using 

evidence-based treatment options. 

DATES: Written comments must be 

received on or by January 2, 2018. 

ADDRESSES: Submit comments by any 

one of the following methods: 

• Internet: Electronic comments may 

be sent via http://www.regulations.gov, 

docket control number CDC–2017–0103. 

Please follow the directions on the site 

to submit comments; or 

• Mail: Comments may also be sent 

by mail to the attention of Pamela 

Lemos, Office on Smoking and Health, 

Centers for Disease Control and 

Prevention, 4770 Buford Highway, Mail 

Stop F–79, Atlanta, GA 30341. 

All relevant comments will be posted 

without change to http://

www.regulations.gov including any 

personal information provided. 

FOR FURTHER INFORMATION CONTACT: 

Pamela Lemos, Office on Smoking and 

Health, Centers for Disease Control and 

Prevention, 4770 Buford Highway, 

Atlanta, GA 30341; Telephone (770) 

488–5709; Email: OSHFRN@cdc.gov. 

SUPPLEMENTARY INFORMATION: 

Scope of Problem 

Cigarette smoking is the leading cause 

of premature death and disease in the 

United States, causing about 480,000 

deaths each year and costing the 

country over $300 billion annually in 

health care spending and lost 

productivity.1 2 Helping tobacco users 

quit completely is the quickest approach 

to reducing tobacco-related disease, 

death, and costs.7 Quitting smoking has 

immediate and long-term health 

benefits.1 While quitting smoking at any 

age is beneficial, smokers who quit by 

the age of 35 to 44 years can prevent 

most of the risk of dying from a 

smoking-related disease.1 8

Most cigarette smokers say that they 

want to quit, more than half try to quit 

each year, and almost three in five 

American adults who ever smoked have 

quit.3 Several treatments are proven 

effective in helping tobacco users quit, 

including individual, group, and 

telephone counseling and seven FDAapproved cessation medications.3 4

Receiving advice to quit and quitting 

assistance from health care providers 

also increases quit rates.4 5 The use of 

both counseling and medication when 

trying to quit is more effective than 

using either method alone.4 5 However, 

only one-third of smokers use 

counseling and/or medication when 

trying to quit, and only one in twenty 

smokers use both.3 While adult cigarette 

smoking rates have been declining 

overall for several decades, certain 

groups continue to smoke at high rates 

and face special challenges in quitting, 

including adults who live below the 

poverty level and adults with behavioral 

health conditions.6 Those with 

behavioral health conditions include 

adults with mental illness or substance 

abuse disorders. The Substance Abuse 

and Mental Health Services 

Administration’s National Survey on 

Drug Use and Health (NSDUH) defines 

mental illness as any diagnosable 

mental, behavioral, or emotional 

disorder and defines substance use 

disorder as dependence or abuse of 

alcohol or illicit drugs. 

Many resources are available to help 

smokers connect with evidence-based 

treatments. Telephone quitlines exist in 

all states and other innovative and 

emerging resources are available such as 

web based platforms, texting, chat, and 

mobile apps. Many smokers, however, 

are unaware of these resources or have 

misconceptions about them. 

Approach 

CDC is seeking information from the 

public to inform future activities that 

could efficiently and cost effectively 

connect tobacco users with evidencebased treatment options to help them 

quit. We plan to use the information 

gathered to inform activities including, 

but not limited to, state tobacco control 

programming, national governmental 

and nongovernmental organization 

work, and other entities that work to 

make broadly available and sustainable 

connections between people who want 

to quit using tobacco and evidencebased cessation assistance. 

The goal of this effort is to ensure that 

all tobacco users who want help quitting 

are aware of and have ready access to 

evidence-based treatment options 

through channels that they are 

comfortable using, including but not 

limited to telephone quitlines. We will 

carefully review and consider all 

comments received to this request for 

information. 

CDC is specifically interested in 

receiving information on the following 

topics: 

(1) How can CDC leverage emerging 

technologies to deliver evidence-based 

cessation interventions through new 

and innovative platforms that have 

broad reach, especially among younger 

adults, those with low income, and 

adults with chronic and/or behavioral 

health conditions? 

(2) What are some innovative 

approaches to reduce the cost—in time, 

staffing, and funding—of providing 

effective cessation services to people 

who want to quit using tobacco? 

(3) How might standardization of 

quitline services achieve greater 

efficiency while also preserving state 

quitlines’ ‘‘brands,’’ flexibility, and 

capacity for innovation? 

(4) What communication channels 

and communication strategies should 

CDC consider employing to ensure that 

both tobacco users, including those 

belonging to high-risk and 

disadvantaged populations, and health 

care providers are aware of and have 

access to evidence-based cessation 

resources? 

(5) What role should CDC, state and 

local health departments, not for profit 

institutions, traditional healthcare 

providers, and/or professional 

healthcare partner organizations, play in 

ensuring that high-risk populations 

(such as smokers living below the 

poverty level or those with behavioral 

health conditions) have access to 

tailored cessation services of 

appropriate intensity to help them 

successfully quit? 


asabaliauskas on DSKBBXCHB2PROD with NOTICES
Federal Register / Vol. 82, No. 209 / Tuesday, October 31, 2017 / Notices 50429 

(6) How can CDC support state and 

local health departments, traditional 

healthcare providers, not for profit 

health institutions, and professional 

healthcare partner organizations to 

ensure that evidence-based tobacco 

cessation interventions are integrated 

into primary and behavioral health care 

settings on a consistent and sustainable 

basis? 

(7) How can the public health sector 

most effectively maximize the impact of 

public and private insurance coverage of 

cessation treatments as part of efforts to 

ensure that all tobacco users have 

barrier-free access to these treatments? 

References 

1. U.S. Department of Health and Human 

Services. The Health Consequences of 

Smoking—50 Years of Progress: A Report 

of the Surgeon General. Atlanta: U.S. 

Department of Health and Human 

Services, Centers for Disease Control and 

Prevention, National Center for Chronic 

Disease Prevention and Health 

Promotion, Office on Smoking and 

Health, 2014. 

2. Xu X, Bishop EE, Kennedy SM, Simpson 

SA, Pechacek TF. Annual Healthcare 

Spending Attributable to Cigarette 

Smoking: An Update. American Journal 

of Preventive Medicine 2014;48(3):326– 

33. 

3. Babb S, Malarcher A, Schauer G, Asman 

K, Jamal A. Quitting Smoking Among 

Adults—United States, 2000–2015. 

MMWR Morb Mortal Wkly Rep 

2017;65:1457–1464. 

4. Siu AL; US Preventive Services Task 

Force. Behavioral and pharmacotherapy 

interventions for tobacco smoking 

cessation in adults, including pregnant 

women: U.S. Preventive Services Task 

Force recommendation statement. Ann 

Intern Med 2015;163:622–34. 

5. Fiore MC, Jae ́n CR, Baker TB, et al. 

Treating Tobacco Use and Dependence: 

2008 Update—Clinical Practice 

Guidelines. Rockville (MD): U.S. 

Department of Health and Human 

Services, Public Health Service, Agency 

for Healthcare Research and Quality, 

2008. 

6. Jamal A, King BA, Neff LJ, Whitmill J, 

Babb SD, Graffunder CM. Current 

Cigarette Smoking Among Adults— 

United States, 2005–2015. MMWR Morb 

Mortal Wkly Rep 2016;65:1205–1211. 

7. Institute of Medicine. Ending the Tobacco 

Problem: A Blueprint for the Nation. 

Washington: The National Academies 

Press, 2007. 

8. Jha P, Ramasundarahettige C, Landsman V, 

Rostron B, Thun M, Anderson RN, 

McAfee T, Peto R. 21st-century hazards 

of smoking and benefits of cessation in 

the United States. New England Journal 

of Medicine 2013;368(4):341–50. 

Dated: October 25, 2017. 

Sandra Cashman, 

Executive Secretary, Centers for Disease 

Control and Prevention. 

[FR Doc. 2017–23669 Filed 10–30–17; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

[CDC–2017–0048; Docket Number NIOSH– 

156–C] 

Final Immediately Dangerous to Life or 

Health (IDLH) Value Profiles 

AGENCY: National Institute for 

Occupational Safety and Health 

(NIOSH) of the Centers for Disease 

Control and Prevention (CDC), 

Department of Health and Human 

Services (HHS). 

ACTION: Notice of availability. 

SUMMARY: NIOSH announces the 

availability of the following four 

Immediately Dangerous to Life or Health 

(IDLH) Value Profile documents: 

Acetonitrile [CAS No. 75–05–8], 

Chloroacetonitrile [CAS No. 107–14–2], 

Methacrylonitrile [CAS No. 126–98–7], 

and Nitrogen dioxide [CAS No. 10102– 

44–0]. 

DATES: The final IDLH Value Profile 

documents were published on 

September 29, 2017. 

ADDRESSES: These documents may be 

obtained at the following link: https://

www.cdc.gov/niosh/idlh/default.html. 

FOR FURTHER INFORMATION CONTACT: R. 

Todd Niemeier, MS, CIH, NIOSH, 

Education and Information Division 

(EID), Robert A. Taft Laboratories, 1090 

Tusculum Ave., MS–C32, Cincinnati, 

OH 45226, phone 513/533–8166 (not a 

toll-free number), email: rbn4@cdc.gov. 

SUPPLEMENTARY INFORMATION: On May 5, 

2017, NIOSH published a request for 

public review in the Federal Register 

[82 FR 21239] on IDLH Value profiles. 

We did not receive public comments, 

but did receive peer and stakeholder 

comments. These comments received 

were reviewed and addressed where 

appropriate. 

Frank Hearl, 

Chief of Staff, National Institute for 

Occupational Safety and Health, Centers for 

Disease Control and Prevention. 

[FR Doc. 2017–23665 Filed 10–30–17; 8:45 am] 

BILLING CODE 4163–19–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Food and Drug Administration 

[Docket No. FDA–2017–N–5897] 

Packaging, Storage, and Disposal 

Options To Enhance Opioid Safety— 

Exploring the Path Forward; Public 

Workshop; Request for Comments 

AGENCY: Food and Drug Administration, 

HHS. 

ACTION: Notice of public workshop; 

request for comments. 

SUMMARY: The Food and Drug 

Administration (FDA, the Agency, or 

we) is announcing the following public 

workshop entitled ‘‘Packaging, Storage, 

and Disposal Options To Enhance 

Opioid Safety—Exploring the Path 

Forward.’’ The purpose of this 2-day 

public workshop is to host a scientific 

discussion with experts and seek input 

from interested stakeholders regarding 

the role of packaging, storage, and 

disposal options within the larger 

landscape of activities aimed at 

addressing abuse, misuse, or 

inappropriate access of prescription 

opioid drug products (opioids); guiding 

principles and considerations for the 

design of packaging, storage, and 

disposal options for opioids; integrating 

packaging, storage, and disposal options 

into existing health care and pharmacy 

systems, including both open and 

closed health care systems (e.g., a closed 

system such as the U.S. Department of 

Veterans Affairs); data needs and how to 

address challenges in assessing the 

impact of packaging, storage, and 

disposal options in both the premarket 

and postmarket settings; and ways in 

which FDA could encourage the 

development and assessment of 

packaging, storage, and disposal options 

for opioids that have the potential to 

enhance opioid safety. 

DATES: The public workshop will be 

held on December 11 and 12, 2017, from 

8:30 a.m. to 5 p.m. Submit either 

electronic or written comments on this 

public workshop by February 12, 2018. 

See the SUPPLEMENTARY INFORMATION

section for registration date and 

information. 

ADDRESSES: The public workshop will 

be held at the Sheraton Silver Spring 

Hotel, 8777 Georgia Ave., Silver Spring, 

MD 20910. The hotel’s phone number is 

301–589–0800. 

You may submit comments as 

follows. Please note that late, untimely 

filed comments will not be considered. 

Electronic comments must be submitted 

on or before February 12, 2018. The 


asabaliauskas on DSKBBXCHB2PROD with NOTICES